Abstract
Objective: The authors observed priapism as aside effect occuring during the intracavernoustreatment of erectile dysfunction. Earlierpriapism had been treated with anintracavernous injection of sympatomimetics;unfortunately several complications andcontraindications were found.Patients and methods: Methylene blue wasapplied in the treatment of five patients.First a corpus cavernosum punction wasperformed and some blood was aspirated from thepenis. Finally 100 mg of Methylthionin Chloratiwas injected into the corpus cavernosum.Results: A sufficient detumescence wasobserved in all of these cases. There were nocomplications. The method was appliedeffectively in two cases after an unsuccessfulpunction.Conclusion: The autors recommendintravenous methylene blue for the treatment ofpriapism. According to their experience thismethod is free of complications and aseffective as a sympathomimetics treatment. Asthey think, it can be recommended in anymanifestations of priapism because its force ofaction appears to be both chemically andbiologically clear.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Perimenis P, Atanasopoulos A, Garamoutsor I et al. The incidence of pharmacologicaly induced priapismus in the diagnostic and therapeutic management of 685 men with erectile dysfunction. Urol Int 2001; 66: 27–29.
Secil M, Arslan D, Goktay AY et al. The prediction of papaverin induced priapism by color Doppler sonography. J Urol 2001; 165: 416–418.
Melman A, Serels S. Priapism. Int J Impot Res 2000; 12: 133–139.
de Holl JD, Shin PA, Angle JF et al. Alternative approaches to the management of priapism. Int J Impot Res 1998; 10: 11–14.
Bravo-Avila ME, Araujo-Alvarez JM, Bustamante-Quezada A et al. Toxicity and hypotensive effect of L-arginin oxoborolidinone and its modulation by methylene blue. Arch Cardiol Mex 2001; 71: 193–198.
Nakanishi H, Matsuoka I, Ono T et al. Qualitatively different response of isolated rabbit aorta to methylene blue administered from intimal and adventitial surface. Fuhushima J Med Science 2001; 47: 63–73.
Rösner M, Wechsel HW, Dichgans J. Intrazerebrale Massenblutung nach intrakavernöser Metaraminol-Behandlung einer prolongierten Erektion. Akt Urol 1995; 26: 427–430.
Martinez-Portillo FJ, Hoang-Boehm J, Weiss J et al. Methylene blue as a succesful treatment alternative for pharmacologicaly induced priapism. Eur Urol 2001; 39: 20–23.
Mc Mahon CG. High flow priapism due to an arterial-lacunar fistule complicating initial veno-occlusive priapism. Int J Impot Res 2002; 14: 195–196.
Steers WD, Selby JB. Use of methylene blue and selective embolisation of the pudendal artery for high flow priapism refractory to medical and surgical treatment. J Urol 1991; 146: 1361–1363.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hübler, J., Szántó, Á. & Könyves, K. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. Int Urol Nephrol 35, 519–521 (2003). https://doi.org/10.1023/B:UROL.0000025617.97048.ae
Issue Date:
DOI: https://doi.org/10.1023/B:UROL.0000025617.97048.ae